Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synthetic Biologics Inc (NYSE MKT LLC:SYN)

1.10
Delayed Data
As of Feb 12
 -0.06 / -5.17%
Today’s Change
0.93
Today|||52-Week Range
4.32
-51.97%
Year-to-Date

Today’s Trading

Previous close1.16
Today’s open1.20
Day’s range1.05 - 1.22
Volume555,492
Average volume (3 months)1,065,148
Market cap$99.9M
Dividend yield--
Data as of 4:02pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-18.52%
Earnings growth (this year)-71.87%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.35

Competitors

 Today’s
change
Today’s
% change
AMPEAmpio Pharmaceutical...+0.02+1.05%
GTXIGTX Inc+0.00+0.01%
LIFEaTyr Pharma Inc+0.31+8.16%
CRMECardiome Pharma Corp+0.04+0.82%
Data as of 4:02pm ET, 02/12/2016

Financials

Next reporting dateMarch 28, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$0.00
Annual profit (last year)-$19.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jeffrey Lucero Riley
Chief Financial Officer, Secretary &
Treasurer
Steven A. Shallcross
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers